Trending News
News
News
Researchers Develop New Method to Generate Human Antibodies
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.
News
Large-Scale Production of Living Brain Cells Enables Entirely New Research
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.
News
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast Milk
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.
News
Superior Pattern Detectors Efficiently Learn to Stereotype
People with higher cognitive abilities are more likely to learn and apply social stereotypes, finds a new study.
News
Visual Blueprints Present From Birth
Harvard Researchers reveal that a primitive blueprint of organization is already present in the brains of primates just a few days after birth and appears to get gradually filled in with age and experience.
News
Agilent Technologies Presents Thought Leader Award to Dr. Ram Sasisekharan
Agilent Technologies awards Dr. Ram Sasisekharan with the Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization.
News
Innate Reaction of Hematopoietic Stem Cells to Severe Infections
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.
News
Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine
The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.
News
CRISPR Reveals New Targets for Promising Cancer Drugs
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.
News
DARPA Pours $65 Million Into Making CRISPR Safer
With one eye on potential bioterrorism threats, the Defense Advanced Research Projects Agency has announced $65 million in funding to seven projects around the USA.
Advertisement